Notis McConarty Edward Takes $294,000 Position in The Clorox Company (NYSE:CLX)

Notis McConarty Edward purchased a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,000 shares of the company's stock, valued at approximately $294,000.

Several other hedge funds also recently bought and sold shares of CLX. OneDigital Investment Advisors LLC purchased a new stake in shares of Clorox in the first quarter valued at $247,000. Brown Miller Wealth Management LLC purchased a new stake in shares of Clorox in the first quarter valued at $399,000. Roman Butler Fullerton & Co. purchased a new stake in shares of Clorox in the first quarter valued at $400,000. Wedge Capital Management L L P NC grew its position in shares of Clorox by 33.5% in the first quarter. Wedge Capital Management L L P NC now owns 28,510 shares of the company's stock valued at $4,198,000 after purchasing an additional 7,159 shares during the period. Finally, Cornerstone Wealth Group LLC grew its position in shares of Clorox by 19.0% in the first quarter. Cornerstone Wealth Group LLC now owns 25,582 shares of the company's stock valued at $3,767,000 after purchasing an additional 4,085 shares during the period. Hedge funds and other institutional investors own 78.53% of the company's stock.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber acquired 4,000 shares of the business's stock in a transaction on Wednesday, May 7th. The shares were purchased at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the purchase, the director directly owned 4,000 shares of the company's stock, valued at $546,280. This represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.57% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. Citigroup reaffirmed a "neutral" rating and issued a $135.00 price objective (down previously from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. Wells Fargo & Company reduced their target price on Clorox from $142.00 to $135.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 9th. JPMorgan Chase & Co. reduced their target price on Clorox from $144.00 to $140.00 and set a "neutral" rating on the stock in a report on Friday. Barclays reduced their target price on Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a report on Tuesday, July 15th. Finally, Evercore ISI set a $140.00 target price on Clorox and gave the company an "underperform" rating in a report on Tuesday, May 6th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $144.83.

Clorox Stock Down 0.5%

Shares of NYSE:CLX traded down $0.62 during trading on Friday, hitting $130.80. The company's stock had a trading volume of 1,287,038 shares, compared to its average volume of 1,776,629. The company has a debt-to-equity ratio of 13.07, a quick ratio of 0.44 and a current ratio of 0.74. The Clorox Company has a fifty-two week low of $117.35 and a fifty-two week high of $171.37. The stock's 50-day moving average price is $126.77 and its two-hundred day moving average price is $140.29. The company has a market capitalization of $16.12 billion, a PE ratio of 23.48, a PEG ratio of 3.46 and a beta of 0.51.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a return on equity of 324.23% and a net margin of 9.89%. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same quarter last year, the firm posted $1.71 EPS. The company's revenue was down 8.0% compared to the same quarter last year. As a group, sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.